China’s Medical Innovation: Hengrui Launches Breakthrough ECMO Technology
Jiangsu Hengrui Pharmaceuticals Co., Ltd. has achieved a significant milestone in China’s medical device industry. The company’s domestically developed Extracorporeal Membrane Oxygenation (ECMO) system received approval from China’s National Medical Products Administration on January 24, 2025. This approval marks Hengrui’s entry into the critical care medical device market, expanding its portfolio beyond pharmaceuticals. Key Features […]